Clinical trial
Clinical Efficacy of Novel Jasminum-based Nano-reinforced Calcium Hydroxide Medicament on Postoperative Pain: a Triple-blind Study
NCT06653608 is registered in ClinicalTrials.gov with Pakistan Institute of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy of Novel Jasminum-based Nano-reinforced Calcium Hydroxide Medicament on Postoperative Pain: a Triple-blind Study
- Lead sponsor
- Pakistan Institute of Medical Sciences
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 24, 2024
- Completion date
- September 25, 2024
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute apical periodontitis of pulpal origin, necrotic pulp